Key result
Experimental data suggest that K+ channel downregulation in heart failure and diabetic cardiomyopathy is driven by a redox-sensitive metabolic mechanism linked to glucose utilization.
Cardiac K+ channel remodelling in heart failure may be driven by a redox-sensitive mechanism linked to glucose utilization, suggesting metabolic modulation as a potential therapeutic approach.
Answers are grounded in this paper and cite their sources.
Supports metabolic modulation as a research target in HF; hypothesis-generating from Level 5 experimental data and requires clinical validation.
Electrical remodelling of the ventricle is a common pathogenic feature of cardiovascular disease states that lead to heart failure. Experimental data suggest this change in electrophysiological phenotype is largely due to downregulation of K(+) channels involved in repolarization of the action potential. 2. Voltage-clamp studies of the transient outward current (I(to)) in diabetic cardiomyopathy support a metabolic mechanism for K(+) channel downregulation. In particular, I(to) density is significantly increased in diabetic rat isolated ventricular myocytes treated in vitro with insulin or agents that activate pyruvate dehydrogenase. Recent data suggest this mechanism is not limited to diabetic conditions, because metabolic stimuli that upregulate I(to) in diabetic rat myocytes act similarly in non- diabetic models of heart failure. 3. Depressed I(to) channel activity is also reversed by experimental conditions that increase myocyte levels of reduced glutathione, indicating that oxidative stress is involved in electrical remodelling. Moreover, upregulation of I(to) density by activators of glucose utilization is blocked by inhibitors of glutathione metabolism, supporting the premise that there is a functional link between glucose utilization and the glutathione system. 4. Electrophysiological studies of diabetic and non-diabetic disease conditions affecting the heart suggest I(to) channels are regulated by a redox-sensitive mechanism, where glucose utilization plays an essential role in maintaining a normally reduced state of the myocyte. This hypothesis has implications for clinical approaches aimed at reversing pathogenic electrical remodelling in a variety of cardiovascular disease states.
No takes yet. Share an insight, caveat, or question.
Rozanski et al. (2002) conducted a review in Cardiovascular disease leading to heart failure and diabetic cardiomyopathy. Activators of glucose utilization (e.g., insulin, pyruvate dehydrogenase activators) was evaluated on Transient outward current (I(to)) density. Experimental data suggest that K+ channel downregulation in heart failure and diabetic cardiomyopathy is driven by a redox-sensitive metabolic mechanism linked to glucose utilization.
Synapse has enriched 10 related papers. Consider them for comparative context: